Ionis Pharmaceuticals Inc
IONS.O- Latest Trade
- trading lower39.09USD
- Change
- -0.04
- % Change
0.10%Negative
- Day Range
- 39.04 - 39.79
- 52-Week Range
- 25.04 - 44.42
As of May 20 2022. Values delayed up to 15 minutes
- Previous Close
- 39.13
- Open
- 39.43
- Volume
- 45,954.00
- 3 Month Average Trading Volume
- 22.86
- Shares Out (Mil)
- 141.80
- Market Cap
- 5,548.55
- Forward P/E
- -15.92
- Dividend Yield
- -99,999.99
Key Statistics
2.68181818 mean rating - 22 analysts
- P/E Excl. Extra Items (TTM)
- -99,999.99
- Price To Sales (TTM)
- 6.60
- Price To Book (Quarterly)
- 7.82
- Price To Cash Flow (Per Share TTM)
- 402.71
- Total Debt/Total Equity (Quarterly)
- 176.46
- Long Term Debt/Equity (Quarterly)
- 175.87
- Return On Investment (TTM)
- -0.18
- Return On Equity (TTM)
- -0.16
2021 (millions USD)
About Ionis Pharmaceuticals Inc
Company Information
Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company is primarily focused on our cardiovascular and neurology franchises. Its products include SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA is for the treatment of patients of all ages with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. TEGSEDI is for the treatment of patients with polyneuropathy caused by hereditary transthyretin (TTR), amyloidosis (hATTR), a debilitating, progressive, and fatal disease. WAYLIVRA is an antisense medicine indicated as an adjunct to diet in adult patients. The Company has over six medicines in Phase III studies for eight indications, which include Eplontersen (TTR), Olezarsen (ApoC-III), Donidalorsen (PKK), ION363 (FUS), Pelacarsen (Apo(a)) and Tofersen (SOD1). Its cardiovascular medicine in development includes Eplontersen, Olezarsen, Pelacarsen, ION449 (PCSK9), Fesomersen and IONIS-AGT-LRx.
Address
2855 Gazelle CtCARLSBAD, CA
92010-6670
United States
Industry
Biotechnology & Drugs
Executive Leadership
- Joseph Loscalzo
- Independent Chairman of the Board
- Brett P. Monia
- Chief Executive Officer, Director
- Elizabeth L. Hougen
- Chief Financial Officer, Executive Vice President - Finance
- C. Frank Bennett
- Executive Vice President, Chief Scientific Officer
- Joseph T. Baroldi
- Executive Vice President, Chief Business Officer
- Onaiza Cadoret - Manier
- Executive Vice President, Chief Product Strategy and Operations Officer
- Richard S. Geary
- Executive Vice President, Chief Development Officer
- Eugene Schneider
- Executive Vice President, Chief Clinical development Officer
- Eric E. Swayze
- Executive Vice President - Research
- Patrick R. O'Neil
- Chief Legal Officer, General Counsel and Corporate Secretary
- B. Lynne Parshall
- Director, Senior Strategic Advisor
- Joseph H. Wender
- Lead Independent Director
- Spencer R. Berthelsen
- Independent Director
- Allene M. Diaz
- Independent Director
- Michael R. Hayden
- Independent Director
- Joan Elizabeth Herman
- Independent Director
- Joseph Klein
- Independent Director
- Frederick T. Muto
- Independent Director
Latest News
- BUZZ U.S. STOCKS ON THE MOVEGroupon, Moderna, Knightscope
The tech-heavy Nasdaq rose nearly 2% on Monday, but was still on track for its worst ever start to the year as investors shied away from stocks with lofty valuations amid aggressive rate hike bets and geopolitical tensions.
- BUZZ U.S. STOCKS ON THE MOVENetflix, Boeing, Ocuphire Pharma
The tech-heavy Nasdaq rose 1% on Monday, but was still on track for its worst start to the year as investors shied away from stocks with lofty valuations amid aggressive rate hike bets and geopolitical tensions.
- MarketsU.S. RESEARCH ROUNDUP Embark Technology, Innovage, IRhythm Technologies
Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Embark Technology, Innovage Holding and IRhythm Technologies, on Friday.
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,836.30 | 0.27%Negative |
| Copper | 772.55 | 0.46%Positive |
| Brent Crude Oil | 112.55 | -- |
| CBOT Soybeans | 1,705.75 | 0.90%Positive |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,901.36 | 0.01%Positive |
| Euro STOXX 50 | 3,657.03 | 0.45%Positive |
| FTSE 100 | 7,389.98 | 1.19%Positive |
| Nikkei 225 | 26,739.03 | 1.27%Positive |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes